• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Costs associated with acute respiratory illness and select virus infections in hospitalized children, El Salvador and Panama, 2012-2013

tetano

Editor, Senior Moderator
J Infect. 2019 May 30. pii: S0163-4453(19)30180-X. doi: 10.1016/j.jinf.2019.05.021. [Epub ahead of print]
[h=1]Costs associated with acute respiratory illness and select virus infections in hospitalized children, El Salvador and Panama, 2012-2013.[/h] Jara JH[SUP]1[/SUP], Azziz-Baumgartner E[SUP]2[/SUP], De Leon T[SUP]3[/SUP], Luciani K[SUP]4[/SUP], Brizuela YS[SUP]5[/SUP], Estripeaut D[SUP]6[/SUP], Castillo JM[SUP]7[/SUP], Barahona A[SUP]3[/SUP], Corro M[SUP]4[/SUP], Cazares R[SUP]5[/SUP], Vergara O[SUP]6[/SUP], Rauda R[SUP]7[/SUP], Rodr?guez R[SUP]8[/SUP], Franco D[SUP]8[/SUP], Widdowson MA[SUP]2[/SUP], Clar? W[SUP]2[/SUP], Alvis-Estrada JP[SUP]9[/SUP], Murray CT[SUP]9[/SUP], Ortega-Sanchez IR[SUP]10[/SUP], Dawood FS[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND AND OBJECTIVES:[/h] Although acute respiratory illness (ARI) is a leading cause of hospitalization among young children, few data are available about cost of hospitalization in middle-income countries. We estimated direct and indirect costs associated with severe ARI resulting in hospitalization among children aged <10 years in El Salvador and Panama through the societal perspective.
[h=4]METHODS:[/h] During 2012 and 2013, we surveyed caregivers of children hospitalized with ARI about their direct medical (i.e. outpatient consultation, medications, hospital fees), non-medical (transportation, childcare), and indirect costs (lost wages) at discharge and 7 days after discharge. We multiplied subsidized hospital bed cost derived from administrative data by hospitalization days to estimate provider costs.
[h=4]RESULTS:[/h] Overall, 638 children were enrolled with a median age of 12 months (IQR 6-23). Their median length of hospitalization was 4 days (IQR 3-6). In El Salvador, caregivers incurred a median of US$38 (IQR 22-72) in direct and indirect costs per illness episode, while the median government-paid hospitalization cost was US$118 (IQR 59-384) generating an overall societal cost of US$219 (IQR 101-416) per severe ARI episode. In Panama, caregivers incurred a median of US$75 (IQR 39-135) iin direct and indirect costs, and the health-care system paid US$280 (IQR 150-420) per hospitalization producing an overall societal cost of US$393 (IQR 258-552).
[h=4]CONCLUSIONS:[/h] The cost of severe ARI to caregivers and the health care system was substantive. Our estimates will inform models to estimate national costs of severe ARI and cost-benefit of prevention and treatment strategies.
Copyright ? 2019. Published by Elsevier Ltd.


PMID: 31153920 DOI: 10.1016/j.jinf.2019.05.021
 
Back
Top Bottom